Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers unprecedented convenience, marking a major…
Read More »HIV Prevention
The Supreme Court upheld the ACA’s process for mandating preventive care coverage, protecting access to PrEP and cancer screenings while…
Read More »
The FDA has approved a groundbreaking biannual injection for HIV prevention, offering near-total protection and new hope for ending the…
Read More »
Trump Administration cuts to U.S. aid have shuttered LGBTQ health centers in Nepal, leaving thousands without access to HIV care,…
Read More »
The Supreme Court is reviewing whether the body recommending preventive services like PrEP under the ACA was properly appointed, in…
Read More »
The 36th Annual Walk to End HIV, hosted by Allies in Hope (formerly AIDS Foundation Houston), is set to take…
Read More »
A twice-yearly shot could end AIDS, but will it reach everyone who needs it? Gilead's HIV prevention drug is 100%…
Read More »
Timely care and support help HIV patients reach a zero-transmission goal. Harris Health's READI program shows how to manage chronic…
Read More »
Since 1988, when it was first recognized by the World Health Organization, the December 1 World AIDS Day observance has…
Read More »